InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-16.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Tousignant Jennifer, Directeur Juridique. Insider active across 1 company, notably Viridian Therapeutics, Inc.\DE. Cumulatively, 2 filings have been logged. Activity tracked since 3 March 2026. The latest transaction was disclosed on 3 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
1,675 shares@ US$30.190.0025% mcap50.0% of flowCommon StockSEC:0001193125-26-099008
1,675 shares@ US$30.190.0025% mcap50.0% of flowCommon StockSEC:0001193125-26-099008:0
2 of 2 declarations
About Tousignant Jennifer
Jennifer Tousignant is the Chief Legal Officer at Viridian Therapeutics, Inc. She is responsible for managing the legal affairs and regulatory compliance of the company. With a strong background in law, Jennifer Tousignant contributes to the overall strategy and regulatory compliance of Viridian Therapeutics, Inc.
